AIM
NH

Acrospire Investment Management’s NantHealth, Inc NH Stock Holding History

Acrospire Investment Management’s Portfolio NH Stock Details NH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-113
Closed -$17K – 2582
2016
Q4 		$17K Buy
113
+46
+69% +$8.14K 0.01% 1826
2016
Q3 		$13K Buy
+67
New +$12.3K 0.01% 1637

Other funds holding NH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Blackstone Inc
Blackstone Inc New York $25.6B AUM 26.83% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
EA
Emerald Advisers Leola, Pennsylvania $4.25B AUM 141.71% 1-Year Est. Return
EMFAT
Emerald Mutual Fund Advisers Trust Leola, Pennsylvania $2.85B AUM 140.52% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
WCM
Wildcat Capital Management New York $229M AUM 132.65% 1-Year Est. Return
HCM
Highbridge Capital Management New York $3.09B AUM 31.21% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
CIA
Capital Impact Advisors Boston, Massachusetts $1.78B AUM 56.11% 1-Year Est. Return

Acrospire Investment Management's NH Position: Q1 2017 in Review

Acrospire Investment Management sold out of NantHealth, Inc (NH) in Q1 2017, closing a stake of 113 shares — an estimated $17K sold.

Acrospire Investment Management first reported a position in NH in Q3 2016 and held it in 2 quarters. The position peaked at $17K in Q4 2016. 48 funds tracked by Wall St. Rank hold NH as of Q1 2017.

  • Acrospire Investment Management reported no remaining NantHealth, Inc position as of Q1 2017 after selling out during the quarter.
  • Acrospire Investment Management sold 113 NantHealth, Inc shares in Q1 2017, an estimated $17K.
  • Acrospire Investment Management first reported a position in NantHealth, Inc in Q3 2016 and held it in 2 quarters.
  • Acrospire Investment Management's NantHealth, Inc position peaked at $17K in Q4 2016.
  • 48 funds tracked by Wall St. Rank held NantHealth, Inc as of Q1 2017.

Based on Acrospire Investment Management's 13F filing for Q1 2017, filed 4 May 2017.